What is the average price of clotrimazole exports from India?

The average unit price for clotrimazole exports from India is $2.30 USD per unit, with prices ranging from $0.00 to $750.18 depending on formulation, packaging, and order volume. The total market is valued at $92.6M across 10,037 shipments.

Which ports handle clotrimazole exports from India?

The primary ports for clotrimazole exports from India are NHAVA SHEVA SEA (INNSA1) (13.7% of shipments), SAHAR AIR (12.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.3% of shipments), JNPT/ NHAVA SHEVA SEA (9.4% of shipments), JNPT (6.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Why is India a leading exporter of clotrimazole?

India is one of the world's leading exporters of clotrimazole due to its large base of 712 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports clotrimazole to 158 countries, demonstrating 81% global market coverage.

What certifications do Indian clotrimazole exporters need?

Indian clotrimazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

How many buyers import clotrimazole from India?

There are 1,728 registered buyers importing clotrimazole from India, spread across 158 countries. The repeat buyer rate is 57.0%, indicating strong long-term trade relationships and consistent product quality.

What is the market share of the top clotrimazole supplier from India?

CAPLIN POINT LABORATORIES LIMITED is the leading clotrimazole exporter from India with a market share of 13.0% and total export value of $12.0M across 302 shipments. The top 5 suppliers together control 47.6% of total export value.

Clotrimazole

India Pharmaceutical Trade Intelligence

$92.6M712 Suppliers158 CountriesHS 30049029

ExportsIndia → NIGERIA12.2%India → TANZANIA7.3%

ImportsUNITED STATES → India$12.8K UNITED KINGDOM → India$10.0K

#1 Supplier: CAPLIN POINT #1 Buyer: NUEVOS ETICOS

Clotrimazole Export Data from India (2026) — Suppliers, Buyers & Trade Stats | TransData Nexus | TransData Nexus

How India Exports Clotrimazole to the World

Q: Who are the top clotrimazole exporters from India?

The top clotrimazole exporters from India are: 1. CAPLIN POINT LABORATORIES LIMITED — $12.0M (13.0% market share); 2. ENCUBE ETHICALS PRIVATE LIMITED — $10.0M (10.8% market share); 3. LINCOLN PHARMACEUTICALS LTD — $8.1M (8.8% market share); 4. S KANT HEALTHCARE LIMITED — $7.2M (7.8% market share); 5. S K AGE EXPORTS — $6.8M (7.3% market share). Together they account for 47.6% of India's total clotrimazole export value.

Q: What is the total export value of clotrimazole from India?

The total export value of clotrimazole from India is $92.6M USD, recorded across 10,037 shipment transactions from 712 active exporters to 158 destination countries. The average shipment value is $9.2K.

Q: Which countries import clotrimazole from India?

India exports clotrimazole to 158 countries worldwide. The top importing countries are: NIGERIA (12.2% share, $11.3M), TANZANIA (7.3% share, $6.7M), AUSTRALIA (7.0% share, $6.5M), UNITED STATES (6.1% share, $5.7M), GUATEMALA (5.4% share, $5.0M). These five markets account for 38.0% of total export value.

Q: What is the HS code for clotrimazole exports from India?

The primary HS code for clotrimazole exports from India is 30049029. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Between 2022 and 2026, India exported $92.6M worth of clotrimazole across 10,037 verified shipments to 158 countries — covering 81% of world markets in the Antifungals segment. The largest destination is NIGERIA (12.2%). CAPLIN POINT LABORATORIES LIMITED leads with a 13.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Clotrimazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Clotrimazole export data snapshot — $92.6M · 712 exporters · 158 countriesTransData Nexus · Indian Customs Data

Top Clotrimazole Exporters from India

712 active exporters · Ranked by export value

View all 712 →

Top Clotrimazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CAPLIN POINT LABORATORIES LIMITED	$12.0M	302	9	13.0%
2	ENCUBE ETHICALS PRIVATE LIMITED

Top Countries Importing Clotrimazole from India

158 destination markets · Ranked by import value

All 158 countries →

Top Countries Importing Clotrimazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NIGERIA	$11.3M	12.2%
2	TANZANIA	$6.7M	7.3%
3	AUSTRALIA	$6.5M	7.0%
4	UNITED STATES	$5.7M	6.1%
5	GUATEMALA	$5.0M	5.4%
6	EL SALVADOR	$4.4M	4.8%
7	GHANA	$4.2M	4.5%
8	UGANDA	$3.8M	4.1%
9	DOMINICAN REPUBLIC	$3.1M	3.3%
10	MOZAMBIQUE	$3.0M	3.3%

NIGERIA is India's largest clotrimazole export destination, absorbing 12.2% of total exports worth $11.3M. The top 5 importing countries — NIGERIA, TANZANIA, AUSTRALIA, UNITED STATES, GUATEMALA — together account for 38.0% of India's total clotrimazole export value. The remaining 153 destination countries collectively receive the other 62.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Clotrimazole to India?

8 origin countries · Total import value: $23.5K

India imports clotrimazole from 8 countries with a combined import value of $23.5K. The largest supplier is UNITED STATES ($12.8K, 29 shipments), followed by UNITED KINGDOM and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Clotrimazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$12.8K	29	54.5%
2	UNITED KINGDOM	$10.0K	3	42.7%
3	CANADA	$408	1	1.7%
4	ISRAEL	$129	2	0.5%
5	UKRAINE	$67	1	0.3%
6	GERMANY	$39	2	0.2%
7	ITALY	$11	1	0.0%
8	AUSTRALIA	$1	2	0.0%

UNITED STATES is the largest supplier of clotrimazole to India, accounting for 54.5% of total import value. The top 5 origin countries — UNITED STATES, UNITED KINGDOM, CANADA, ISRAEL, UKRAINE — together supply 99.8% of India's clotrimazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Clotrimazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, clotrimazole is approved for various formulations, including topical creams, lozenges, and otic solutions. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for clotrimazole products, indicating a competitive generic market. Notably, on September 26, 2025, the FDA approved an ANDA for Clotic (clotrimazole otic solution) by Carwin Pharmaceutical Associates. As of January 8, 2026, no generic version of Clotic is available in the U.S. market.

The presence of 712 active Indian exporters underscores the robust supply chain catering to the U.S. market. However, exporters must navigate the FDA's stringent regulatory pathways, including compliance with Current Good Manufacturing Practices (cGMP) and potential import alerts. Ensuring adherence to these regulations is crucial for maintaining market access and avoiding disruptions.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, clotrimazole is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Manufacturers must obtain approval for their products, demonstrating compliance with EU Good Manufacturing Practice (GMP) standards. For instance, in September 2011, the EMA recommended the suspension of the marketing authorization for Canazole (clotrimazole cream 1%) in Ireland due to concerns over its benefit-risk balance. (ema.europa.eu)

This highlights the importance of continuous monitoring and compliance with regulatory standards to maintain market authorization within the EU and UK.

3WHO Essential Medicines & Global Standards

Clotrimazole is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in treating fungal infections globally. The 24th edition of the list, published on September 5, 2025, reaffirms clotrimazole's essential status. (who.int)

Additionally, clotrimazole formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and efficacy across different markets.

4India Regulatory Classification

In India, clotrimazole is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, clotrimazole is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics.

For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products. Exporters must ensure compliance with these requirements to facilitate smooth international trade.

5Patent & Exclusivity Status

Clotrimazole's primary patents have expired, leading to a competitive generic market globally. This patent expiration has enabled numerous manufacturers to produce and export clotrimazole, contributing to the substantial number of active Indian exporters and the extensive global reach of the product.

6Recent Industry Developments

In May 2025, the WHO's 25th Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming clotrimazole's inclusion. (who.int)

In September 2025, the FDA approved Carwin Pharmaceutical Associates' ANDA for Clotic (clotrimazole otic solution), expanding treatment options for otic fungal infections in the U.S. market.

In January 2026, the WHO published the 10th edition of the Model List of Essential Medicines for Children, continuing to list clotrimazole as an essential antifungal treatment for pediatric use. (who.int)

These developments reflect the ongoing recognition of clotrimazole's importance in global health and the dynamic regulatory landscape affecting its production and distribution.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Clotrimazole

Retail & reference prices across 9 markets vs. India FOB export price of $2.30/unit

Global Price Benchmark for Clotrimazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	No specific government or regulatory pricing information is available for Clotrimazole 500mg vaginal tablets in the United States.
United Kingdom	N/A	GBP	No specific government or regulatory pricing information is available for Clotrimazole 500mg vaginal tablets in the United Kingdom.
Germany	N/A	EUR	No specific government or regulatory pricing information is available for Clotrimazole 500mg vaginal tablets in Germany.
Australia	N/A

Supply Chain Risk Assessment — Clotrimazole

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, while robust in manufacturing Active Pharmaceutical Ingredients (APIs) like Clotrimazole, remains significantly dependent on China for Key Starting Materials (KSMs). This reliance exposes the supply chain to vulnerabilities, as disruptions in Chinese production can lead to shortages and price volatility. For instance, in recent years, environmental regulations in China have led to the shutdown of several API manufacturers, causing supply disruptions and cost escalations for Indian pharmaceutical companies.

The COVID-19 pandemic further highlighted these vulnerabilities. Lockdowns and logistical challenges in China during 2020 and 2021 disrupted the supply of essential KSMs to India, impacting the production of various APIs, including Clotrimazole. This situation underscored the need for India to enhance its domestic production capabilities to mitigate risks associated with over-reliance on a single foreign source.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Clotrimazole from India account for 47.6% of the total export value, with CAPLIN POINT LABORATORIES LIMITED leading at a 13.0% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact the global supply chain.

Access Complete Clotrimazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 10,037 transactions across 158 markets.

Request Demo View Pricing

Frequently Asked Questions — Clotrimazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top clotrimazole exporters from India?

The leading clotrimazole exporters from India are CAPLIN POINT LABORATORIES LIMITED, ENCUBE ETHICALS PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LTD, and 12 others. CAPLIN POINT LABORATORIES LIMITED leads with 13.0% market share ($12.0M). The top 5 suppliers together control 47.6% of total export value.

What is the total export value of clotrimazole from India?

The total export value of clotrimazole from India is $92.6M, recorded across 10,037 shipments from 712 active exporters to 158 countries. The average shipment value is $9.2K.

Which countries import clotrimazole from India?

India exports clotrimazole to 158 countries. The top importing countries are NIGERIA (12.2%), TANZANIA (7.3%), AUSTRALIA (7.0%), UNITED STATES (6.1%), GUATEMALA (5.4%), which together account for 38.0% of total export value.

What is the HS code for clotrimazole exports from India?

The primary HS code for clotrimazole exports from India is 30049029. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Clotrimazole

Clotrimazole

Top Clotrimazole Exporters from India

Top Countries Importing Clotrimazole from India

Who Supplies Clotrimazole to India?

Quick Facts

Related Antifungals

Related Analysis

Need Details?

Regulatory Landscape — Clotrimazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Clotrimazole

Supply Chain Risk Assessment — Clotrimazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Clotrimazole Trade Intelligence

Frequently Asked Questions — Clotrimazole Exports from India

Who are the top clotrimazole exporters from India?

What is the total export value of clotrimazole from India?

Which countries import clotrimazole from India?

What is the HS code for clotrimazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of clotrimazole exports from India?

Which ports handle clotrimazole exports from India?

Why is India a leading exporter of clotrimazole?

What certifications do Indian clotrimazole exporters need?

How many buyers import clotrimazole from India?

What is the market share of the top clotrimazole exporter from India?

Analysis Methodology